Aarti Drugs Limited (NSE:AARTIDRUGS)
489.85
+0.40 (0.08%)
Aug 4, 2025, 1:30 PM IST
DFS Market Cap
Aarti Drugs has a market cap or net worth of 44.99 billion as of August 1, 2025. Its market cap has decreased by -8.16% in one year.
Market Cap
44.99B
Enterprise Value
50.92B
Revenue
24.22B
Ranking
n/a
PE Ratio
23.83
Stock Price
$489.85
Market Cap Chart
Since April 23, 2002, Aarti Drugs's market cap has increased from 351.91M to 44.99B, an increase of 12,685.48%. That is a compound annual growth rate of 23.16%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 44.99B | 6.24% |
Dec 31, 2024 | 42.35B | -5.81% |
Dec 29, 2023 | 44.96B | 5.55% |
Dec 30, 2022 | 42.60B | -15.47% |
Dec 31, 2021 | 50.39B | -23.35% |
Dec 31, 2020 | 65.75B | 387.61% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,910.20B |
Divi's Laboratories | 1,688.78B |
Cipla | 1,213.89B |
Mankind Pharma | 1,059.19B |
Apollo Hospitals Enterprise | 1,057.03B |
Zydus Lifesciences | 954.97B |
Fortis Healthcare | 648.70B |
Aurobindo Pharma | 627.15B |